Sign in
Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years
Aaron Nagiel, MD, PhD
Annual Meeting Talks
2024
Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
2019
Category: AMD-Neovascular